Quick Takeaways
- Novo Holdings A/S filed SCHEDULE 13D for MAPLIGHT THERAPEUTICS, INC. Voting Common Stock, par value $0.0001 per share (MPLT).
- Disclosed ownership: 8.4%.
- Date of event: 28 Oct 2025.
Novo Holdings A/S - 28 Oct 2025 SCHEDULE 13D Report for MAPLIGHT THERAPEUTICS, INC. Voting Common Stock, par value $0.0001 per share (MPLT)
- Filing Manager
- Novo Holdings A/S
- Reporting Manager
- Novo Holdings A/S
- Symbol
- MPLT
- Shares outstanding
- 43,888,357 shares
- Disclosed Ownership
- 3,686,622 shares
- Ownership
- 8.4%
- Form type
- SCHEDULE 13D
- Filing time
- 04 Nov 2025, 16:21:27 UTC
- Date of event
- 28 Oct 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Novo Holdings A/S disclosed 8.4% ownership in MAPLIGHT THERAPEUTICS, INC. Voting Common Stock, par value $0.0001 per share (MPLT) on 28 Oct 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 04 Nov 2025, 16:21.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Novo Holdings A/S | 8.4% | 3,686,622 | 3,686,622 | 0 | /s/ Barbara Fiorini | Novo Holdings A/S By Barbara Fiorini, General Counsel, Finance & Operations | 0001388325 |